DarioHealth (DRIO) Short term Debt (2022 - 2025)

DarioHealth (DRIO) has reported Short term Debt for 4 consecutive years, with $10.3 million the latest figure, recorded in Q1 2025.

• For the quarter ending Q1 2025, Short term Debt rose 160.37% year-over-year to $10.3 million; the trailing twelve-month figure through Mar 2025 stood at $10.3 million (up 160.37% YoY), and the FY2024 full-year result was $5.5 million, up 37.86% from the prior year.
• Short term Debt advanced to $10.3 million in Q1 2025 per DRIO's latest filing, from $5.5 million in the prior quarter.
• Across five years, Short term Debt topped out at $10.3 million in Q1 2025 and bottomed at $373000.0 in Q1 2022.
• Historically, Short term Debt has averaged $5.3 million across 4 years, with a median of $5.2 million in 2024.
• The widest YoY moves for Short term Debt: up 2201.07% in 2023, down 55.19% in 2023.
• Over 4 years, Short term Debt stood at $8.8 million in 2022, then sank by 55.19% to $4.0 million in 2023, then soared by 37.86% to $5.5 million in 2024, then surged by 88.86% to $10.3 million in 2025.
• According to Business Quant data, Short term Debt over the past three periods registered $10.3 million, $5.5 million, and $8.7 million for Q1 2025, Q4 2024, and Q3 2024 respectively.